|
18 Sep 2013 |
Primary Endpoint Achieved in CAVATAK Phase 2 Melanoma Trial
|
|
18 Sep 2013 |
StemCells, Inc. Announces New Preclinical Data Showing HuCNS-SC(R) Cells Preserve Visual Function by Keeping Photoreceptors Normal and Healthy
|
|
17 Sep 2013 |
Regado Biosciences, Inc. Enrolls First Patient in Phase 3 Trial of REG1
|
|
16 Sep 2013 |
FDA Lifts Clinical Hold of Pluristem's Phase II Intermittent Claudication Study
|
|
13 Sep 2013 |
Sangamo BioSciences Announces Presentation of Clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects Treated with SB-728-T
|
|
12 Sep 2013 |
Coronado Biosciences Announces Initiation of Phase 2 Study Evaluating TSO in Ulcerative Colitis
|
|
11 Sep 2013 |
Kiadis Pharma Completes Five-year Follow-up of its Phase I/II Clinical Study with Blood Cancer Product ATIR™ and Study Meets Primary Objective
|
|
10 Sep 2013 |
First Patient Treated In Phase II Of Neuralstem ALS Stem Cell
|
|
09 Sep 2013 |
Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer
|
